Skip to main content
Erschienen in: European Radiology 5/2019

30.11.2018 | Interventional

Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure

verfasst von: Dong Ik Cha, Tae Wook Kang, Kyoung Doo Song, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim, Dong Hyun Sinn, Kyunga Kim

Erschienen in: European Radiology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare the therapeutic outcomes and safety of radiofrequency (RF) ablation for subcardiac and non-subcardiac hepatocellular carcinoma (HCC) and to evaluate the risk factors for technical failure of the procedure.

Methods

This retrospective study was approved by the institutional review board. Between September 2002 and May 2016, 73 patients with subcardiac HCC and the same number of patients with non-subcardiac HCC matched by tumor size were included. Subcardiac HCC was defined as an index tumor that was located ≤ 1 cm from the pericardium in axial or coronal images. Cumulative local tumor progression (LTP) was compared between the two groups using the log-rank test. Prognostic factors for technical failure were assessed using multivariable logistic analysis.

Results

Technical success rates between both groups were not significantly different (91.8% in the subcardiac HCC group vs. 95.9% in the non-subcardiac HCC group; p = 0.494). The cumulative LTP rates were 15.4% and 19.1% at 3 and 5 years, respectively, in the subcardiac HCC group, and 10.7% and 15.5% in the non-subcardiac HCC group, without significant difference (p = 0.862). The distance between the index tumor and pericardium (odds ratio [OR], 0.14; p = 0.023) and tumor in segment IV (reference, left lateral sector; OR, 36.53; p = 0.029) were significant factors for technical failure in patients with subcardiac HCC.

Conclusions

RF ablation was an effective treatment for subcardiac HCC. However, tumor location should be considered in the planning of treatment to avoid technical failure.

Key Points

RF ablation for subcardiac HCC is technically feasible without major complications.
RF ablation was an effective treatment for subcardiac HCC in terms of LTP.
Risk factors for technical failure were distance of the index tumor from the heart (cutoff value of 0.5 cm) and the location of the tumor (segment IV).
Literatur
1.
Zurück zum Zitat Shady W, Petre EN, Gonen M et al (2016) Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes--a 10-year experience at a single center. Radiology 278:601–611CrossRefPubMed Shady W, Petre EN, Gonen M et al (2016) Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes--a 10-year experience at a single center. Radiology 278:601–611CrossRefPubMed
2.
Zurück zum Zitat European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
3.
Zurück zum Zitat Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306CrossRefPubMed Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306CrossRefPubMed
4.
Zurück zum Zitat Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–765CrossRefPubMed Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–765CrossRefPubMed
5.
Zurück zum Zitat Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRefPubMed Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRefPubMed
6.
Zurück zum Zitat Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRefPubMed Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRefPubMed
7.
Zurück zum Zitat Kim SW, Rhim H, Park M et al (2009) Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 10:366–376CrossRefPubMedPubMedCentral Kim SW, Rhim H, Park M et al (2009) Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 10:366–376CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Song I, Rhim H, Lim HK, Kim YS, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–2640CrossRefPubMed Song I, Rhim H, Lim HK, Kim YS, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–2640CrossRefPubMed
9.
Zurück zum Zitat Kang TW, Rhim H, Kim EY et al (2009) Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol 10:34–42CrossRefPubMedPubMedCentral Kang TW, Rhim H, Kim EY et al (2009) Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol 10:34–42CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kang TW, Lim HK, Lee MW et al (2016) Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 280:300–312CrossRefPubMed Kang TW, Lim HK, Lee MW et al (2016) Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 280:300–312CrossRefPubMed
11.
Zurück zum Zitat Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360CrossRefPubMed Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360CrossRefPubMed
12.
Zurück zum Zitat Llovet JM, Vilana R, Brú C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRefPubMed Llovet JM, Vilana R, Brú C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRefPubMed
13.
Zurück zum Zitat Loh KB, Bux SI, Abdullah BJ, Raja Mokhtar RA, Mohamed R (2012) Hemorrhagic cardiac tamponade: rare complication of radiofrequency ablation of hepatocellular carcinoma. Korean J Radiol 13:643–647CrossRefPubMedPubMedCentral Loh KB, Bux SI, Abdullah BJ, Raja Mokhtar RA, Mohamed R (2012) Hemorrhagic cardiac tamponade: rare complication of radiofrequency ablation of hepatocellular carcinoma. Korean J Radiol 13:643–647CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kim YS, Lim HK, Rhim H et al (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed Kim YS, Lim HK, Rhim H et al (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed
15.
Zurück zum Zitat Rhim H, Choi D, Kim YS, Lim HK, Choe BK (2010) Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol 75:253–258CrossRefPubMed Rhim H, Choi D, Kim YS, Lim HK, Choe BK (2010) Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol 75:253–258CrossRefPubMed
16.
Zurück zum Zitat Lee S, Kang TW, Cha DI et al (2018) Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: propensity score analyses of long-term outcomes. J Hepatol 69:70–78 Lee S, Kang TW, Cha DI et al (2018) Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: propensity score analyses of long-term outcomes. J Hepatol 69:70–78
17.
Zurück zum Zitat Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H (2013) First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol 68:e641–e651CrossRefPubMed Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H (2013) First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol 68:e641–e651CrossRefPubMed
18.
Zurück zum Zitat Min JH, Lim HK, Lim S et al (2014) Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 20:61–70CrossRefPubMedPubMedCentral Min JH, Lim HK, Lim S et al (2014) Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 20:61–70CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kang TW, Kim JM, Rhim H et al (2015) Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection--propensity score analyses of long-term outcomes. Radiology 275:908–919CrossRefPubMed Kang TW, Kim JM, Rhim H et al (2015) Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection--propensity score analyses of long-term outcomes. Radiology 275:908–919CrossRefPubMed
20.
Zurück zum Zitat Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273:241–260CrossRefPubMed Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273:241–260CrossRefPubMed
21.
Zurück zum Zitat Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL (2017) Cirse quality assurance document and standards for classification of complications: the Cirse Classification System. Cardiovasc Intervent Radiol 40:1141–1146CrossRefPubMed Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL (2017) Cirse quality assurance document and standards for classification of complications: the Cirse Classification System. Cardiovasc Intervent Radiol 40:1141–1146CrossRefPubMed
22.
Zurück zum Zitat Omary RA, Bettmann MA, Cardella JF et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293–S295CrossRefPubMed Omary RA, Bettmann MA, Cardella JF et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293–S295CrossRefPubMed
23.
Zurück zum Zitat Carberry GA, Smolock AR, Cristescu M et al (2017) Safety and efficacy of percutaneous microwave hepatic ablation near the heart. J Vasc Interv Radiol 28:490–497CrossRefPubMed Carberry GA, Smolock AR, Cristescu M et al (2017) Safety and efficacy of percutaneous microwave hepatic ablation near the heart. J Vasc Interv Radiol 28:490–497CrossRefPubMed
24.
Zurück zum Zitat Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47:458–472CrossRefPubMed Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47:458–472CrossRefPubMed
25.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171CrossRefPubMedPubMedCentral Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101–1108CrossRefPubMed Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101–1108CrossRefPubMed
27.
Zurück zum Zitat Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–885CrossRefPubMed Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–885CrossRefPubMed
Metadaten
Titel
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
verfasst von
Dong Ik Cha
Tae Wook Kang
Kyoung Doo Song
Min Woo Lee
Hyunchul Rhim
Hyo Keun Lim
Dong Hyun Sinn
Kyunga Kim
Publikationsdatum
30.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5868-2

Weitere Artikel der Ausgabe 5/2019

European Radiology 5/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.